Mankind Pharma Limited (India) holds 32 active US FDA Type II Drug Master Files, has DMF or CEP filings on record for 29 active ingredients and is linked to 2 FDA-registered manufacturing sites. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Mankind Pharma Limited: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/mankind-pharma-limited

Overview

Mankind Pharma Limited is a leading pharmaceutical company based in India, dedicated to improving healthcare in the country and beyond. The company provides a wide range of high-quality and affordable medications spanning multiple therapeutic areas.

Core services & business areas

Pharmaceutical ManufacturingRegulatory AffairsProduct DevelopmentSales and Marketing

Therapeutic areas

Active ingredients with DMF or CEP filings

Substances for which Mankind Pharma Limited holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Mankind Pharma Limited holds 32 active (32 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • PERFLUOROHEXYLOCTANEActive2026-03-27
  • LIFITEGRASTActive2026-03-18
  • EMPAGLIFLOZINActive2025-09-30
  • EMPAGLIFLOZIN (PROCESS II)Active2025-02-27
  • MIDODRINE HYDROCHLORIDE USPActive2024-11-18
  • CILNIDIPINEActive2024-05-01
  • ROCURONIUM BROMIDE USPActive2024-03-28
  • CLOZAPINE USPActive2023-02-01
  • SUCCINYLCHOLINE CHLORIDE USPActive2022-07-25
  • VILDAGLIPTINActive2022-07-02
  • BACLOFEN USPActive2022-04-27
  • TELMISARTAN USPActive2022-03-23
  • REVEFENACINActive2022-02-18
  • TICAGRELORActive2022-02-01
  • SACUBITRIL VALSARTAN TRISODIUM (AMORPHOUS)Active2022-01-17
  • ROSUVASTATIN CALCIUM USPActive2021-12-22
  • VALSARTAN DISODIUMActive2021-11-02
  • PANTOPRAZOLE SODIUM USP (PROCESS II)Active2021-10-18
  • SACUBITRIL SODIUMActive2021-10-12
  • ATORVASTATIN CALCIUM USP (PROCESS II)Active2021-09-30
  • SITAGLIPTIN PHOSPHATEActive2021-03-31
  • PROPRANOLOL HYDROCHLORIDE USPActive2021-03-05
  • PANTOPRAZOLE SODIUM USPActive2020-12-07
  • CLOMIPRAMINE HYDROCHLORIDE USPActive2020-07-30
  • ATORVASTATIN CALCIUM USPActive2020-06-05
  • RANOLAZINEActive2020-03-31
  • HALOPERIDOL DECANOATE USPActive2020-02-26
  • HALOPERIDOL USPActive2019-11-22
  • AMITRIPTYLINE HYDROCHLORIDE USPActive2019-07-24
  • SUGAMMADEX SODIUMActive2019-07-18
  • NITROFURANTOIN MACROCRYSTALS USPActive2019-02-23
  • NITROFURANTOIN MONOHYDRATE USPActive2018-12-28

Registered manufacturing sites (2)

Physical sites registered with the US FDA and resolved to Mankind Pharma Limited, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Mankind Pharma Limited in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this Mankind Pharma Limited?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.